Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Savara Inc | c97582e10vk.htm |
| EX-31.2 - EXHIBIT 31.2 - Savara Inc | c97582exv31w2.htm |
| EX-21.1 - EXHIBIT 21.1 - Savara Inc | c97582exv21w1.htm |
| EX-31.1 - EXHIBIT 31.1 - Savara Inc | c97582exv31w1.htm |
| EX-32.1 - EXHIBIT 32.1 - Savara Inc | c97582exv32w1.htm |
| EX-10.63 - EXHIBIT 10.63 - Savara Inc | c97582exv10w63.htm |
| EX-10.59 - EXHIBIT 10.59 - Savara Inc | c97582exv10w59.htm |
| EX-10.65 - EXHIBIT 10.65 - Savara Inc | c97582exv10w65.htm |
| EX-10.45 - EXHIBIT 10.45 - Savara Inc | c97582exv10w45.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the registration statements on Form S-8 (No.
333-126551 and No. 333-151903) and the registration statements on Form S-3 (No. 333-117022, No.
333-127857, No. 333-113824, No. 333-159376 and No. 333-164177) of our report dated March 18, 2010
with respect to our audit of the consolidated financial statements of ADVENTRX Pharmaceuticals,
Inc. and Subsidiaries (a development stage enterprise) as of December 31, 2009 and 2008, and for
the years then ended, and for the period from January 1, 2002 through December 31, 2009, which
report appears in this Annual Report on Form 10-K for the year ended December 31, 2009.
/s/ J.H. COHN LLP
San Diego, California
March 18, 2010
March 18, 2010